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Abstract
Background: A large survey was carried out in 2008 in Europe to evaluate the efficacy of
fenbendazole (FBZ), pyrantel (PYR), ivermectin (IVM) and moxidectin (MOX), i.e. the major
anthelmintic molecules used in current practice against cyathostomins affecting horses.A total of
102 yards and 1704 horses was studied in three countries: 60 yards and 988 horses from Italy, 22
and 396 from the UK, 20 and 320 from Germany. The survey consisted of Faecal Egg Count
Reduction Tests (FECRTs) with a faecal egg count reduction (FECR) categorization of (I) resistance
present if FECR <90% and the lower 95% confidence limit (LCL) <90%, (II) resistance suspected if
FECR ≥90% and/or LCL <90% and (III) no resistance if FECR ≥90% and LCL >90%.The calculation
of FECR data was performed employing bootstrap analysis of group arithmetic means.
Results: The testing of FBZ on a total of 80 yards resulted in resistance present on more than 80%
of the UK and German yards and on significantly fewer in Italy, i.e. in 38% (p<0.01). PYR, IVM and
MOX were tested on a total of 102 yards.For PYR resistance present was found in 25% of the yards
with no significant differences between countries.For IVM resistance present was encountered in one
Italian and two UK yards (3%),resistance present to MOX was not found in any yard in any country.
Conclusions: The results indicate that single and/or multiple drug resistance in equine
cyathostomins is present in the three countries,is widespread particularly for FBZ and/or PYR and
Open AccessBackground
In recent years, the spread of nematode populations
resistant to parasiticides has become a serious threat for
animal health, welfare and production in many areas of
the world. Suppressive treatment strategies and/or abuse
of anthelmintics have resulted in selection of drug-
resistant parasites of horses belonging to the Cyatho-
stominae subfamily (Nematoda, Strongylida), i.e. cyatho-
stomins or small strongyles [1-3]. The control of horse
cyathostominosis usually relies on three major classes of
anthelmintics, the benzimidazoles - BZs (e.g. fenben-
dazole - FBZ), the tetrahydropyrimidines - THP (i.e.
pyrantel-PYR salts) and the macrocyclic lactones - MLs
(i.e. ivermectin-IVM and moxidectin-MOX). Resistance to
BZs is widespread with prevalence up to 100% in some
countries where it is now almost impossible to find
susceptible parasite populations [3]. Reports in the early
90’s [4] indicate that resistance to THP is presently
increasing in Europe and North America as well [5]. IVM
and MOX have shown full efficacy against cyathostomins
until the past two years, when cases of reduced efficacy of
IVM in UK [6], Germany [7] and US [8] have been
published. Very recently, the failure of MLs to provide
control of cyathostomins in Brazil has been also reported
[9]. Indeed, such a situation represents an alarm bell
ringing if one considers the important pathogenic
potential played by small strongyles, as they are the cause
of severe intestinal syndromes at both the adult and larval
stages [9-11]. Furthermore, when the larvae encysted in
the intestinal wall simultaneously emerge, they induce
the potentially life-threatening “larval cyathostominosis”,
a colitis with loss of protein and weight, severe diarrhoea,
and oedema [12-14].
The movement of horses between countries and the
virtually global spread of cyathostomins, regardless of
their status of susceptibility to parasiticides, [1] underline
the significant need to enhance our knowledge of the
actual changes in the occurrence and spread of anthel-
mintic resistant populations in different parts of the
world. In Europe cyathostomins resistant to one (“single
resistance”) or more (“multiple resistance”) anthelmintic
class have been reported in a range of countries [15-21].
The majority of these studies have relied on a small
number of horse yards in limited areas. Therefore, given
the merit in geographically and numerically broader
investigations of drug resistance on horse farms, the
present large scale survey has evaluated the efficacy of the
major drugs used in current practice against cyatho-
stomins and the prevalence of resistant populations in
three European countries.
Methods
Yards and animals
In 2008 a total of 146 yards and 4280 horses were
screened in Europe for the presence of cyathostomin
infection. These were 84 yards and 2105 horses from Italy,
32 and 1059 from the UK, and 30 and 1116 from
Germany, respectively. Such a pre-treatment screening was
performed with faecal egg counts (FEC) on all horses
present on the yards [22]. A value of ≥50 eggs per gram
(EPG) of faeces in 12 to 20 horses was used as a cut-off for
inclusion of properties in the survey. This resulted in a
total of 102 yards and 1704 horses studied in the three
countries: 60 yards and 988 horses from Italy, 22 and 396
from the UK, 20 and 320 from Germany.
Faecal Egg Count Reduction Test
All horses were subjected to a Faecal Egg Count Reduction
Test (FECRT). The pre-FECRT screening prior to Day 0 was
followed by random allocation of the animals in each
yard to equally sized treatment groups of 4 or 5 horses
each, depending on the number of horses with positive
FECs. On Day 0, animals enrolled in each group were
orally treated with either FBZ, PYR, IVM or MOX at the
dosages recommended for the treatment of horse
cyathostominosis. Each treatment was performed by
veterinary practitioners for the different yards (see
acknowledgments). To determine the individual pre-treat-
ment and post-treatment EPG values, faecal samples were
collected for each animal pre-dosing on Day 0 and two
weeks later (Day 14). All FECs were performed at the
Parasitology Laboratory at the Faculty of Veterinary
Medicine, University of Teramo. Within 24 hours of
receipt, the individual samples were subjected to
quantitative coproscopic analysis [22].
The calculation of the FECR percentages was performed
using the newly developed computer program ‘‘BootStreat’’
[23], based on bootstrapping methods. This program
allows calculation of the mean efficacy of the treatment
and provides confidence intervals based on re-sampling-
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in one UK yard multiple resistance present was detected to FBZ, PYR and IVM. Macrocylic
lactones proved to be the most effective drugs, with some evidence of resistance to IVM and
highest activity of MOX, despite a single case of reduced efficacy in Germany.These data call for
the development and implementation,among practitioners,owners and managers,of further plans
to reduce the expansion of the anthelmintic resistant populations and to use those anthelmintics
that remain effective in a manner that preserves their efficacy as long as possible.bootstraps [24]. The efficacy data usually do not follow a
Gaussian distribution and confidence intervals cannot be
calculated. Bootstrap analysis is one approach for
evaluating confidence intervals on non-Gaussian
distributions. Here arithmetic means of the pre- and post-
treatment FEC were used to calculate the group FECR
according to the formula
1 - FEC post-treatment
FECR= 100 ×
FEC pre-treatment
and the lower and upper 95% confidence limits using a
re-sampling number of 2000. Based on the methods
recommended by the World Association for the
Advancement of Veterinary Parasitology [22] for the
detection of anthelmintic resistance in horses and
ruminants, and a previous US study on large numbers of
yards and horses [25], the obtained FECRs were
categorized for all tested compounds as follows: (I)
resistance present if FECR <90% and the lower 95%
confidence limit (LCL) <90%, (II) resistance suspected if
FECR ≥90% and/or LCL <90% and (III) no resistance if
FECR  ≥90% and LCL >90%. To statistically analyse
differences concerning the distribution of resistance on
yards in the three countries for each of the four tested
compounds, the categorized results were examined using
Fischer’s exact test.
Post-treatment larval cultures from each yard were
performed from pooled faecal samples collected from each
treatment group. Pooled faeces were mixed with oak saw-
dust and water. Coprocultures were incubated for 10 days at
27°C and after incubation third-stage larvae (L3) were
harvested using baermanization, examined using a light
microscope and identified using morphological keys [26].
Results
All four compounds were evaluated in 80 yards (50, 17
and 13 from Italy, UK, Germany respectively) where
sufficient cyathostomin infected horses were available for
four treatment groups. FBZ was excluded in 22 yards,
where a smaller number of horses was available after
EPG pre-screening (10, 5, 7 from Italy, UK, Germany
respectively).
Treatment with FBZ resulted in resistance present in 19 out
of 50 (38%), 14 out of 17 (82.4%) and 11 out of 13
(84.6%) yards, resistance suspected in 8 (16%), 2 (11.8%)
and 0 (0%) yards and no resistance in 23 (46%), 1 (5.8%)
and 2 (15.4%) in Italy, UK and Germany, respectively. As
for PYR, resistance present was found in 18 out of 60
(30%), 4 out of 22 (18.2%) and 4 out of 20 (20%) yards,
resistance suspected was found in 17 (28.3%), 2 (9.1%)
and 4 (20%) yards and no resistance in 25 (41.7%), 16
(72.7%) and 12 (60%) for Italy, UK and Germany,
respectively. Treatment with IVM resulted in resistance
present in 1 out of 60 (1.7%), 2 out of 22 (9.1%) and 0
(0%), resistance suspected in 3 (5%), 1 (4.5%) and 1 (5%)
and no resistance in 56 (93.3%), 19 (86.4) and 19 (95%)
for Italy, UK and Germany, respectively. Treatment with
MOX was 100% effective in all yards examined in Italy
and UK. The same 100% efficacy was found for 86 out of
a total of 87 horses treated with MOX in Germany, this
one horse led to a FECR <100% in one German yard.
Mean percentage efficacies of different parasiticides
evaluated in each enrolled yard and respective 95%
confidence intervals are listed in Additional file 1 for the
three countries.
Among countries, the distribution of yards showing FECR
data categorized as indicative for anthelmintic resistance
differed significantly only for FBZ, whereas for the other
three compounds no significant differences were found.
In Italy, only about one third of the farms were
categorized as resistance present compared to more than
80% in UK and Germany (p<0.01). On farms where all
four compounds were tested, the occurrence of multiple
resistance, i.e. categorization as resistance present for
more than one compound, was seen on 10 (20%, n=50)
Italian, 5 (29.4%, n=17) UK and 3 (23.1%, n=13) German
farms. Multiple resistance always included FBZ and PYR,
except for one Italian (FBZ and IVM) and two UK (FBZ
and IVM, and FBZ and PYR and suspected for IVM) yards.
In one of the UK farms resistance was found to FBZ, PYR
and IVM, thus encompassing all the three chemical drug
classes. MOX retained 100% efficacy on this site.
Evaluation of results for individual horses, showed 0-
100% range of efficacy for FBZ and PYR in each of the
three countries (Table 1). IVM showed a range of 0-100%
efficacy in UK and Italy, with incomplete efficacy found in
four Italian, three UK and one German yard (Table 1).
MOX was 100% effective in all treated horses from the
three countries with the exception of a single horse in a
yard from Germany, which displayed a FECR <100% for
this compound (Additional file 1 and Table 1). Addi-
tional File 1 shows mean percentages of FECR and
respective confidence intervals, set between 0 and 100%.
The microscopic examination of the in vitro L3s collected
by the Baermann technique performed on the cultured
post-treatment faecal pools according to their respective
midgut cell numbers showed that they belonged
exclusively to the Cyathostominae subfamily (Figure 1).
Discussion and conclusions
This multinational survey, the largest carried out so far to
evaluate the efficacy of major anthelmintic drugs against
Parasites & Vectors 2009, 2(Suppl 2):S2 http://www.parasitesandvectors.com/content/2/S2/S2
Page 3 of 7
(page number not for citation puroposes)equine cyathostomins, demonstrated that resistant
cyathostomin populations to FBZ and PYR are
widespread in Europe, with higher prevalence for the
former drug. Individual horse FECs showed considerable
variability in the susceptibility status to FBZ, PYR and
even IVM within yards (Table 1).
The calculation of the 95% confidence interval provided
strong evidence for the significance of the FECR% and for
the presence of drug resistance in cyathostomins affecting
horses in Italy, UK and Germany. A single-dose use of FBZ
was ineffective in all but 3 yards examined in the UK and
demonstrated reduced efficacy in almost all German
properties. In Italy, the efficacy of FBZ was found to be
reduced in about one third of the yards. The data
generated in this survey suggest that PYR has also lost
efficacy against small strongyles in the European
countries investigated. Indeed, reduced efficacy to PYR was
found in all three countries involved in this survey and
resistance present in about 20-30% of the examined yards.
However it should be taken into consideration that the
intrinsic efficacy of PYR appears to be generally lower
than that of the ML drugs [27].
This survey confirmed that the efficacy of MLs against
cyathostomins remains high. However, there were yards
(one in Italy and two in the UK) where the FECR efficacy
of IVM was observed to be <90% (LCL<90%) which is
considered as resistance. While a reduced efficacy of IVM
has been already detected in UK in the past years [6], the
present results report the first evidence for reduced
efficacy of this molecule in controlling small strongyles in
Italy as well.
The results of this survey indicate that MOX is 100% effec-
tive in treating the infection caused by cyathostomins in
Europe, the only exception was a single horse in yard n. 19
from Germany (Additional file 1), which was positive for a
post-treatment FEC of 50 (i.e. 75% FECR) two weeks after
the treatment (Table 1). Such a result led to a FECR of
<100% for MOX in this sole yard out of the 102 yards
examined in this survey. Noteworthy, MOX was recently
reported to no longer provide control of cyathostomin
infection in Brazil [9].
Previous studies have already shown that cyathostomin
populations resistant to BZs are present in Europe. The
prevalence of resistance in Switzerland was shown to be
greater than 50% of yards examined [28], and prevalence
rates up to 75-100% were reported in Sweden [29],
Denmark [15], England [30], Slovak Republic [31] and
Germany [18]. Similarly, resistance to PYR has been
previously described both in Europe [4,19,20,32] and the
USA [25,33]. Therefore, the overall outlook demonstrated
by this broad survey undoubtedly enhances the concern
regarding the spread of anthelmintic resistance in horse
cyathostomins. This information provides some basic
knowledge to prompt and improve awareness of
resistance and to stimulate the use of parasiticides in
programmes that minimize selection for resistance. In
fact, erroneous practices such as underdosing, over-use,
and off label use of anthelmintic products are known to
be the basis for the selection of resistant parasite
populations. The results reported here highlight that
present strategies for worm control in horses have to be
re-considered. For instance, the low prevalence of
resistance to THP found in most of the world with the
exception of the US, was explained in the past by the
common practice of daily feeding of low-dose PYR
tartrate in North America. This might have a strong
impact in the selection for resistance also to other PYR
salts [25]. The levels of reduced efficacy of PYR found in
all three EU countries in this survey, where the daily
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Table 1 - Minimum (min) and maximum (max) percentage (%) values of faecal egg count reduction after treatment with fenbendazole (FBZ), pyrantel
(PYR), ivermectin (IVM) and moxidectin (MOX) evaluated against cyathostomins in yards (Y) and horses (H) located in Italy, UK and Germany.
Italy % (min-max)  UK % (min-max)  Germany % (min-max)
YHYHYH
FBZ 32.4-100 0-100 15-100 0-100 11.5-100 0-100
PYR 50.7-100 0-100 70.5-100 0-100 75-100 0-100
IVM 80-100 0-100 70-100 0-100 95.7-100 78.5-100
MOX 100 100 100 100 95-100 75-100
Figure 1
Post-treatment larval culture: cyathostomin third stage larva.feeding is not practiced, demonstrate that such a
programme is just one of many practices leading to
selection for drug-resistant parasites. Another relevant
example is represented by the widespread loss of efficacy
of BZs and PYR in UK, where the over-treatment of
thoroughbreds in the past likely caused the spread of
worm populations resistant to these classes [34]. Worthy
of note is that recently Dudeney et al. [35] have reported
that resistance to MLs is starting to develop in cyatho-
stomins in the UK. Of particular importance and concern
is the finding of relatively high proportions of yards
exhibiting signs of resistance to more than one drug class
in parallel and most noteworthy the first finding of
multiple FBZ/PYR/IVM resistance cyathostomins in UK.
Some drug classes, such as the cyclooctadepsipeptides,
paraherquamides, amino-acetonitrile derivatives, are the
novel anthelmintics that are being used [36-38] but their
potential applicability to horse cyathostomins is un-
known. Therefore, if the extent of resistance to MLs
increases and spreads, horse owners and equine
veterinary practitioners will face an important problem
with no ready solution. Given the real threat that the
resistance to MLs may worsen or spread through horse
movement, there is an urgent need to appropriately use
the remaining effective drugs, especially MOX, in order to
preserve their efficacy.
Horse yards should be regularly monitored not only for
resistance to BZs and PYR, but also to MLs. Over-use of IVM
and MOX could be avoided in those properties where the
other anthelmintics are still highly effective. Specifically,
the drug resistance status should be established on each
property at least on an annual basis and, where effective,
BZs and PYR should be also administered to reduce the
pressure on MLs [9,25]. It has been suggested that each
newly introduced horse should be quarantined and treated
with IVM, since the still constant 100% efficacy of MOX
could hide the first signs of resistance to IVM [9]. However,
in light of the findings in this study, the use of IVM as a
quarantine treatment may allow the unintended intro-
duction of resistant cyathostomins. An alternative would be
to use MOX as the best option for avoiding the intro-
duction of resistant parasites to the site. The active monitor-
ing of anthelmintic effectiveness needs to take into
consideration the egg reappearance period of IVM [7]. If
the IVM-treated animal sheds cyathostomin eggs after
4 weeks rather than 6 to 8 weeks, the status of the animal is
worth further evaluation with sensitive quantitative
copromicroscopic evaluations [9].
Another key point to be taken into account is the
maintenance of the refugia, which provide an useful
dilution of the resistant genes in the parasitic popula-
tions. The preservation of the refugia  while controlling
cyathostomins at the same time requires routine FECs to
identify the horses actually needing an anthelmintic
treatment. This approach is different from the commonly
used interval dose program (i.e. treat-all-animals) and
would avoid the treatment of animals that are currently
being treated more frequently than necessary. Usually, the
majority of the horses on a property shows a low level of
faecal egg shedding, while the greater part of the
cyathostomin populations is present in a small propor-
tion of horses that shows moderate-high FECs [5,25,39].
Thus a knowledge of the FEC values is recommended as
the cornerstone for the necessity to treat. An indicative
minimum cut-off of 200 EPG [9,25,39] has been recom-
mended as a guide to the need for treatment of individual
horses.  This would achieve the dual goal of controlling
cyathostomin-induced health problems while simul-
taneously reducing pasture contamination. The analysis of
the screening FECs data pre-FECRT (not shown) of the
present survey demonstrated that there was a higher
percentage of “high egg shedders” (i.e. >150 EPG) than
“low or null egg shedders” (i.e. <150 EPG), thus confirming
that current control programs are not ideal and providing
further support for the value of conducting FECs before
planning any anthelmintic treatment in a yard. Leaving a
proportion of horses untreated would maximize the refugia
with a little impact on overall control, as horses with low
egg count are not important sources of environmental
contamination. Additionally, the egg shedding from
untreated animals would dilute the presence on the pasture
of any eggs shed by treated animals possibly infected with
resistant populations. In this way the selection pressure
would be progressively reduced [9,25].
In conclusion, given the strong impact that resistant
cyathostomins can and will likely have on horse health,
future parasite control plans should be based on
integrated measures represented by correct use of
anthelmintics and other approaches, such as adequate
pasture hygiene, low stocking rates and mixed grazing
with other animals [9,40,41]. It is essential that owners,
managers and veterinary practitioners take an active and
leading role in planning and monitoring effective and
appropriate worm control programs for horses.
Additional files
Additional file 1
Table showing mean percentages of faecal egg count
reduction after treatment with fenbendazole (FBZ),
pyrantel (PYR), ivermectin (IVM) and moxidectin (MOX)
evaluated against cyathostomins in a total of 102 horse
yards located in Germany, Italy and UK. The faecal egg
count reductions (%) and respective 95% confidence
intervals (CI) (set between 0 and 100%) were calculated
using the Bootstreat programme using the formula FECR=
100 * (1 – arithmetic mean of FEC post treatment/
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H: treated horses in each yard; G: number of horses in
each treatment group.
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